Commerce Bank Sells 5,400 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Commerce Bank lessened its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 39.3% in the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 8,352 shares of the company’s stock after selling 5,400 shares during the period. Commerce Bank’s holdings in Henry Schein were worth $609,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. California State Teachers Retirement System lifted its position in shares of Henry Schein by 1.7% during the 1st quarter. California State Teachers Retirement System now owns 212,108 shares of the company’s stock valued at $16,018,000 after buying an additional 3,534 shares in the last quarter. Tidal Investments LLC lifted its holdings in Henry Schein by 21.4% during the first quarter. Tidal Investments LLC now owns 5,632 shares of the company’s stock valued at $425,000 after purchasing an additional 994 shares in the last quarter. Wahed Invest LLC boosted its position in shares of Henry Schein by 14.3% in the first quarter. Wahed Invest LLC now owns 2,540 shares of the company’s stock worth $192,000 after purchasing an additional 318 shares during the period. Swedbank AB purchased a new stake in shares of Henry Schein in the first quarter worth $215,998,000. Finally, DNB Asset Management AS raised its position in shares of Henry Schein by 18.5% during the 2nd quarter. DNB Asset Management AS now owns 26,731 shares of the company’s stock valued at $1,713,000 after purchasing an additional 4,176 shares during the period. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several recent analyst reports. Evercore ISI upped their target price on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research report on Wednesday, August 7th. Barrington Research reissued an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. JPMorgan Chase & Co. cut their price objective on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a report on Monday, August 12th. Finally, StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Six investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $78.89.

Insider Activity at Henry Schein

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Stock Performance

Henry Schein stock opened at $76.84 on Tuesday. The company’s 50-day moving average price is $70.89 and its 200-day moving average price is $69.73. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The company has a market cap of $9.58 billion, a PE ratio of 31.62, a price-to-earnings-growth ratio of 2.15 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The business had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the business posted $1.32 earnings per share. On average, equities research analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.